Traditional Dietary Advice Vs. Mediterranean Diet in IBS

Sponsor
Sheffield Teaching Hospitals NHS Foundation Trust (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05985018
Collaborator
(none)
134
2
10

Study Details

Study Description

Brief Summary

Irritable bowel syndrome (IBS) affects 5-10% of the population, and incurs substantial health impairment and healthcare utilization. Over 80% of individuals with IBS report food to trigger or aggravate symptoms, with many seeking to undertake dietary modifications. Current guidelines recommend first-line therapy with the relatively straightforward traditional dietary advice, with the more complex and restrictive low FODMAP diet reserved as second-line therapy.

There is emerging data suggesting that the Mediterranean diet may also improve the symptoms of IBS, although it has not yet been subject to any head-to-head randomized dietary trials to help position it within the treatment algorithm. Given the relative ease of implementing the Mediterranean diet, alongside its recognized cardio-metabolic and mental health benefits, studying its efficacy in IBS is attractive as it could potentially pave the way for another first-line dietary option being available to patients before escalating to the demanding and resource intensive second-line therapies.

The investigators will perform a randomized trial comparing the clinical efficacy of traditional dietary advice vs. a Mediterranean diet in IBS. Following dietary randomization, participants will complete validated questionnaires to assess changes in IBS symptoms, quality of life, mood, somatic symptoms, nutritional status, as well as dietary satisfaction and adherence.

Condition or Disease Intervention/Treatment Phase
  • Other: Traditional Diet
  • Other: Mediterranean Diet
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
134 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Randomized Trial of Traditional Dietary Advice Versus Mediterranean Diet in Irritable Bowel Syndrome
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Jul 1, 2024
Anticipated Study Completion Date :
Jul 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Traditional Dietary Advice

Its main elements are to adopt sensible eating habits and avoid excess fatty foods, spicy foods, processed foods, caffeine, fizzy drinks and alcohol.

Other: Traditional Diet
Provided as an educational leaflet

Active Comparator: Mediterranean Diet

The principle components is a diet rich in vegetables, pulses, whole grains, and olive oil

Other: Mediterranean Diet
Provided as an educational leaflet

Outcome Measures

Primary Outcome Measures

  1. Proportion of IBS patients experiencing clinical response with traditional dietary advice vs. Mediterranean diet [Baseline to Week 6]

    IBS symptom severity scale (IBS-SSS) where a 50-point reduction denotes a meaningful clinical response

Secondary Outcome Measures

  1. Changes in individual items of the IBS-SSS [Baseline to Week 6]

    IBS- SSS contains 5 specific questions (pain severity, pain frequency, abdominal distension severity, bowel movement satisfaction, quality of life) with score ranging from 0-100. Change in individual items will be compared within- and between- groups.

  2. Changes in Anxiety and Depression [Baseline to Week 6]

    The four-item patient health questionnaire (PHQ-4) for anxiety and depression is a validated questionnaire assessing mood, with higher scores representing worse mood. Change in scores will be compared within- and between- groups

  3. Changes in Somatic Symptom reporting [Baseline to Week 6]

    The validated patient health questionnaire-12 assess extra-intestinal somatic symptoms, with higher scores representing greater somatic symptom severity. Change in scores will be compared within- and between- groups

  4. Changes in quality of life [Baseline to Week 6]

    The validated Short form 8 Quality of life Questionnaire assesses quality of life, with higher scores representing better quality of life. Change in scores will be compared within- and between- groups

  5. Dietary satisfaction to assigned intervention [Week 6]

    The Diet Satisfaction Score is a 10-item questionnaire assessing dietary satisfaction to an allocated diet (either Mediterranean diet or traditional diet), with higher scores representing greater satisfaction. Changes in score will be compared between the groups.

  6. Adherence to the Mediterranean diet [Week 6]

    The 14-point Mediterranean Diet Adherence Screener will check adequate dietary adherence, which we expect will be seen in those assigned a Mediterranean diet compared with traditional diet. Higher scores represent better adherence.

  7. Changes in nutritional intake [Baseline to Week 6]

    The Comprehensive Nutritional Assessment Questionnaire assesses macronutrient and micronutrient intake, FODMAPs, fibre, starch, glycaemic index/load. Change in scores will be compared within- and between- groups. Only a subset will complete this

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • IBS Symptom Severity Scale(IBS-SSS) > 75

  • Online access

  • English literate

Exclusion Criteria:
  • Organic gastrointestinal diseases (e.g. inflammatory bowel disease, GI cancer, coeliac disease, microscopic colitis, bile acid diarrhoea)

  • Major abdominal surgery (except laparoscopy, appendectomy, cholecystectomy)

  • History of eating disorder

  • Body mass index <20

  • Current dietary interventions

  • Current use of opioids/antibiotics

  • Titrating dose of neuromodulators

  • Severe systemic disease (e.g. cardiac, renal, respiratory, psychiatric) necessitating frequent medical consultations/hospitilisations

  • Pregnant

  • Diabetes mellitus

  • Scleroderma

  • Memory impairment

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Sheffield Teaching Hospitals NHS Foundation Trust

Investigators

  • Principal Investigator: Imran Aziz, Sheffield Teaching Hospitals NHS Foundation Trust

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Imran Aziz, Consultant Gastroenterologist and Senior Lecturer, Sheffield Teaching Hospitals NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT05985018
Other Study ID Numbers:
  • IRAS 259079: TDA vs. MD in IBS
First Posted:
Aug 9, 2023
Last Update Posted:
Aug 9, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 9, 2023